Legal Representation
Attorney
Mark J. Diliberti
USPTO Deadlines
Next Deadline
190 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
January 23, 2026
Extension Available
Until July 23, 2025
Application History
32 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jul 9, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jul 8, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Jul 8, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Jul 8, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Mar 4, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jan 14, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Jan 14, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Jan 13, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jul 23, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
May 28, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
May 28, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
May 8, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Apr 23, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Apr 15, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Apr 15, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Apr 15, 2024 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Apr 15, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Mar 26, 2024 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
Mar 26, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Mar 26, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Feb 7, 2024 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
Feb 7, 2024 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
Feb 7, 2024 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
Feb 2, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Feb 1, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Feb 1, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Jan 10, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Jan 10, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Jan 10, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Jan 9, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
May 8, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Apr 17, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Therapeutic pharmaceutical for the treatment of wounds; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations for wounds; hydrogel for medical purposes; syringes sold filled with hydrogel for medical purposes; syringes sold filled with temperature sensitive hydrogel for medical purposes; therapeutic agents for use in the treatment of wounds; syringes sold filled with therapeutic agents for use in the treatment of wounds; therapeutic pharmaceuticals for use in the treatment of wounds; syringes sold filled with therapeutic pharmaceuticals for use in the treatment of wounds; therapeutic agents featuring antimicrobial preservatives for use in the treatment of wounds; syringes sold filled with therapeutic agents featuring antimicrobial preservatives for use in the treatment of wounds; pharmaceutical preparations, namely, a drug delivery system comprised of topical antiseptics that may be added to appropriate gels and polymer delivery system for the continuous release of a wide variety of therapeutic agents; syringes sold filled with pharmaceutical preparations and substances for the treatment of damaged skin and tissue; antibiotics; mixed antibiotic preparations for use in the treatment of general and local bacteria; syringes sold filled with antibiotics; antiseptics; antiseptic preparations for use in the treatment of general and local bacteria; syringes sold filled with antiseptics; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of wounds
Classification
International Classes
005